Indrayani Biotech Ltd. Announces Rights Issue of ₹49.90 Crore with 5:7 Ratio

Indrayani Biotech Ltd. has announced the outcome of its Rights Issue Committee Meeting held on 9th April, 2026. The committee has approved the terms of the Rights Issue, which includes the issuance of 3,25,25,897 equity shares at a price of ₹15 per share (including a premium of ₹5 per share), amounting to ₹49.90 crore. The record date for the Rights Issue is Tuesday, 28th April, 2026, and the Rights Issue period begins on Wednesday, 27th May, 2026, and ends on Thursday, 25th June, 2026. The rights entitlement ratio is 5 Rights Equity Shares for every 7 fully paid-up equity shares held by the eligible equity shareholders as on the record date. The arrangement for the credits of the rights entitlements has been made with NSDL and CDSL for the credits of the rights entitlements with a separate ISIN in dematerialized form in the demat account of the Eligible Equity Shareholders against the equity shares held by them as on the Record Date.